Showing 15 posts of 552 posts found.


Sanofi set to pay $11.9 million to resolve kickback probe, US Justice Department announces

March 2, 2020
Sales and Marketing Co pays, Justice department, Medicaid, Medicare, Sanofi, insurance

The Justice Department have announced that Sanofi SA have agreed to pay $11.85 million to resolve allegations it used a …


World’s second largest API company to be created by Sanofi

February 25, 2020
Manufacturing and Production API, APIs, China API, Coronavirus API, India API, Sanofi

Sanofi plans to create a new company in Europe dedicated to the production and marketing of active pharmaceutical ingredients (API). …

Sanofi axes four major players from its executive committee

February 13, 2020
Manufacturing and Production, Medical Communications Sanofi, appointments, pharma

Sanofi has announced it will cull its executive committee under plans orchestrated by new Chief Executive Officer Paul Hudson, who …


Sanofi and Regeneron’s Libtayo approved on NHS Scotland for cutaneous squamous cell carcinoma

February 11, 2020
Manufacturing and Production, Sales and Marketing Libtayo, NHS, Regeneron, Sanofi, Scotland, nhs scotland, pharma

Scottish patients will now be able to access Sanofi and Regeneron’s Libtayo (cemiplimab) via the NHS after it became known …


Sanofi charged in birth defects case in France

February 4, 2020
Manufacturing and Production Sanofi, Sanofi Birth Defects, Sanofi France

Sanofi has been charged with failure to adequately warn patients about their anti-epilepsy drug which has been linked to birth …


Top Ten most popular articles on this week

January 17, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Big Pharma, European Commission, FDA, Pakistan, Sanofi, Teva

Pakistan is cracking down on corruption and has registered cases against 200 pharmaceutical companies, while in the US the FDA …

Sanofi secures expanded European approval for Toujeo in type 1 diabetes

January 10, 2020
Medical Communications, Sales and Marketing EU, Sanofi, pharma, toujeo

Sanofi has revealed that the European Commission has expanded the existing label for Toujeo (insulin glargine 300 units/mL) to include …

Sanofi to move away from diabetes and cardiovascular, as company shakeup continues

December 10, 2019
Manufacturing and Production ASH 19, Sanofi, Sanofi Diabetes, Sanofi Insulin, diabetes, insulin

Sanofi has said it will stop investment and research into creating new diabetes and cardiovascular drugs, as part of the …


South Korea jails executives for their role in Samsung Biologics fraud

December 10, 2019
Manufacturing and Production Samsung phones, Sanofi, Sanofi Diabetes, South Korea Healthcare System, South Korea Samsung, diabetes, inhaled insulin, insulin, south korea

Three executives of Samsung Electronics have been sentenced to jail for their role in committing fraud at its biotech affiliate …

Sanofi acquires biotech firm Synthorx for $2.5 billion

December 9, 2019
Sales and Marketing Genetic Alphabet, Sanofi, acute lymphoblastic leukaemia, leukaemia

Sanofi has agreed to buy California-based biotechnology firm Synthrox, in a deal worth about $2.5 billion (£1.95 billion). Paul Hudson, …


Sanofi’s head of strategy and business development to retire amid company review

November 25, 2019
Sales and Marketing Bristol Meyers, Gilead, Sanofi, Shell

One of Sanofi’s most senior strategy bosses is set to retire at the end of the month. Muzammil Mansuri, Executive …


FDA approves Sanofi’s quadrivalent flu vaccine for over-65s

November 6, 2019
Research and Development, Sales and Marketing FDA, Fluzone, Sanofi, flu, influenza, pharma

Sanofi’s quadrivalent influenza vaccine Fluzone High Dose has secured FDA approval in adult patients over the age of 65 for …

Promising Phase 3 data for Sanofi’s Toujeo secures CHMP recommendation of label expansion in type 1 diabetes

November 4, 2019
Research and Development, Sales and Marketing EU, Sanofi, Type 1 diabetes, diabetes, pharma, toujeo

Sanofi took the opportunity at the International Society for Pediatric and Adolescent Diabetes 45th Annual Conference in Boston, Massachusetts to …

European Commission approves Sanofi’s Dupixent in chronic rhinosinusitis with nasal polyposis

October 30, 2019
Research and Development, Sales and Marketing Dupixent, EU, Sanofi, pharma

Sanofi’s Dupixent (dupilumab) has secured European approval for the treatment of chronic rhinosinusitis with nasal polyposis (CRSwNP), it has emerged. …

Sanofi’s Jevtana doubles progression-free survival in metastatic castration-resistant prostate cancer

October 1, 2019
Manufacturing and Production, Research and Development ESMO 2019, Jevtana, Sanofi, pharma, prostate cancer

Sanofi was present at the 2019 European Society of Medical Oncology (ESMO) Congress in Barcelona this year to reveal new …

Latest content